134 Recruiting Trials

Clinical Trials for COVID-19

COVID-19 trials study antiviral agents, monoclonal antibodies, long-COVID interventions, and vaccine platforms for prevention and treatment of SARS-CoV-2 infection.

Showing 15 of 134 recruiting trials

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
PHASE3 Duarte, California +4 more NCT03808922
Recruiting
Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine
PHASE3 Overland Park, Kansas NCT07655180
Recruiting
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
PHASE3 Tucson, Arizona +4 more NCT06631287
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
PHASE3 Phoenix, Arizona +4 more NCT05261139
Recruiting
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
PHASE1 Los Angeles, California +1 more NCT06810934
Recruiting
Arginine Replacement Therapy in COVID-19
PHASE2 Atlanta, Georgia NCT05855330
Recruiting
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
PHASE2 Dallas, Texas NCT05886816
Recruiting
Convalescent Plasma as a Possible Treatment for COVID-19
PHASE2 Chicago, Illinois NCT04442191
Recruiting
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
PHASE4 Chicago, Illinois NCT06008860
Recruiting
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
PHASE1 Decatur, Georgia +4 more NCT07536308
Recruiting
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
PHASE1 Las Vegas, Nevada +1 more NCT07445971
Recruiting
Positron Emission Tomography (PET) Imaging of Thrombosis
PHASE1 Boston, Massachusetts NCT03830320
Recruiting
Dime La VerDAD: Verify, Debunk, and Disseminate
NA Chicago, Illinois +3 more NCT06417762
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
NA Birmingham, Alabama +4 more NCT05218083
Recruiting
Playing Game to Learn About Children's Vaccine Project
NA Chandler, Arizona NCT05984849
Recruiting
See all 134 results
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
COVID-19 Trials by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon